Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Changwen Ke and Nanshan Zhong.
Changwen Ke
Connection Strength
0.434
Nanshan Zhong
  1. Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China. Emerg Infect Dis. 2017 07; 23(8):1332-1340.
    View in: PubMed
    Score: 0.182
  2. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006 Jan; 11(1):49-53.
    View in: PubMed
    Score: 0.081
  3. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates. ACS Nano. 2021 02 23; 15(2):2738-2752.
    View in: PubMed
    Score: 0.058
  4. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Nat Commun. 2020 08 21; 11(1):4207.
    View in: PubMed
    Score: 0.056
  5. Expert consensus-based laboratory testing of SARS-CoV-2. J Thorac Dis. 2020 Aug; 12(8):4378-4390.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.